Analysis of protein profiles in human epithelial ovarian cancer tissues by proteomic technology

European Journal of Gynaecological Oncology

Volumn 31, Issue 1, 2010, Pages 55-62

  Chow, S N ^a,b   Chen, R J ^a   Chen, C H ^a   Chang, T C ^a   Chen, L C ^c   Lee, W J ^a   Shen, J ^d   Chow, L P ^e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b MIN SHENG GENERAL HOSPITAL   (Taiwan)

^c Digitalgene Biosciences Co Ltd   (Taiwan)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Matrix assisted laser desorption ionization time of fight mass spectrometry; Ovarian cancer; Proteomics; Two dimensional gel electrophoresis

Indexed keywords

CATHEPSIN B; CELLULAR RETINOL BINDING PROTEIN; DJ 1 PROTEIN; GALECTIN 1; GAMMA ACTIN; HEAT SHOCK PROTEIN 27; HLA ANTIGEN CLASS 2; PREALBUMIN; PROTEIN; SH3 BINDING GLUTAMIC RICH LIKE PROTEIN; TROPOMYOSIN 4; TUBULIN SPECIFIC CHAPERONE A; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FINGER DERMATOGLYPHICS; HUMAN; HUMAN TISSUE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OVARY CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEOMICS; SEARCH ENGINE; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77349101807     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A. et al.: "Cancer statistics, 2005". CA Cancer J. Clin., 2005, 55, 10.
2. Bast R.C. Jr., Klug T.L., St John E., Jenison E., Niloff J.M., Lazarus H. et al.: "A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer". N. Engl. J. Med., 1983, 309, 883.
3. Markman M.: "CA-125: an evolving role in the management of ovarian cancer". J. Clin. Oncol., 1996, 14, 1411.
4. Wilkins M.R., Sanchez J.C., Gooley A.A., Appel R.D., Humphery-Smith I., Hochstrasser D.F. et al.: "Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it". Biotechnol. Genet. Eng. Rev., 1996, 13, 19.
5. Reynolds T: "For proteomics research, a new race has begun". J. Natl. Cancer Inst., 2002, 94, 552.
6. Wu W., Hu W., Kavanagh J.J.: "Proteomics in cancer research". Int. J. Gynecol. Cancer, 2002, 12, 409.
7. Alaiya A.A., Franzen B., Mobeiger B., Silfversward C., Linder S., Auer G.: "Two-dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity". Electrophoresis, 1999, 20, 1039.
8. Bengtsson S., Krogh M., Szigyarto C.A., Uhlen M., Schedvins K., Silfversward C. et al.: "Large-scale proteomics analysis of human ovarian cancer for biomarkers". J. Proteome Res., 2007, 6, 1440.
9. Blum H., Beier H., Gross H.J.: "Improved silver staining of plant proteins, RNA and DNA in Polyacrylamide gels". Electrophoresis, 1987, 8, 93.
10. Cvetkovic D., Williams S.J., Hamilton T.C.: "Loss of cellular retinol-binding protein 1 gene expression in microdissected human ovarian cancer". Clin Cancer Res., 2003, 9, 1013.
11. Kuppumbatti Y.S., Bleiweiss I.J., Mandeli J.P., Waxman S., Mira Y.L.R.: "Cellular retinol-binding protein expression and breast cancer". J. Natl Cancer Inst., 2000, 92, 475.
12. Jeronimo C., Henrique R., Oliveira J., Lobo F., Pais I., Teixeira M.R. et al.: "Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer". J. Clin. Pathol., 2004, 57, 872.
13. Danguy A., Camby I., Kiss R.: "Galectins and cancer". Biochim. Biophys. Acta, 2002, 1572, 285.
14. Monaco H.L.: "The transthyretin-retinol-binding protein complex". Biochim. Biophys. Acta, 2000, 1482, 65.
15. Zhang Z., Bast R.C. Jr., Yu Y., Li J., Sokoll L.J., Rai A.J. et al.: "Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer". Cancer Res., 2004, 64, 5882.
16. Nishikawa H., Ozaki Y., Nakanishi T., Blomgren K., Tada T., Arakawa A. et al.: "The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer". Gynecol. Oncol., 2004, 92, 881.
17. Oesterreich S., Weng C.N., Qiu M., Hilsenbeck S.G., Osborne C.K., Fuqua S.A.: "The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines". Cancer Res., 1993, 53, 4443.
18. Langdon S.P., Rabiasz G.J., Hirst G.L., King R.J., Hawkins R.A., Smyth J.F. et al.: "Expression of the heat shock protein HSP27 in human ovarian cancer". Clin. Cancer Res., 1995, 1, 1603.
19. Arts H.J., Hollema H., Lemstra W., Willemse R.H., De Vries E.G., Kampinga H.H. et al.: "Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis". Int. J. Cancer, 1999, 84, 234.
20. Cesareni G., Panni S., Nardelli G., Castagnoli L.: "Can we infer peptide recognition specificity mediated by SH3 domains?". FEBS Lett., 2002, 513, 38.
21. Majid S.M., Liss A.S., You M., Bose H.R.: "The suppression of SH3BGRL is important for v-Rel-mediated transformation". Oncogene, 2006, 25, 756.
22. Tian G., Huang Y., Rommelaere H., Vandekerckhove J., Ampe C., Cowan N.J.: "Pathway leading to correctly folded beta-tubulin". Cell, 1996, 86, 87.
23. Nagakubo D., Taira T., Kitaura H., Ikeda M., Tamai K., Iguchi-Ariga S.M. et al.: "DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras". Biochem. Biophys Res. Commun., 1997, 231, 509.
24. Kim R.H., Peters M., Jang Y., Shi W., Pintilie M., Fletcher G.C. et al.: "DJ-1, a novel regulator of the tumor suppressor PTEN". Cancer Cell., 2005, 7, 263.
25. Shinbo Y., Taira T., Niki T., Iguchi-Ariga S.M., Ariga H.: "DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3". Int. J. Oncol., 2005, 26, 641.
26. Qi Y., Chiu J.F., Wang L., Kwong D.L., He Q.Y.: "Comparative proteomic analysis of esophageal squamous cell carcinoma". Proteomics, 2005, 5, 2960.
27. Raval G.N., Bharadwaj S., Levine E.A., Willingham M.C., Geary R.L., Kute T. et al.: "Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors". Oncogene, 2003, 22, 6194.
28. Li D.Q., Wang L., Fei F., Hou Y.F., Luo J.M., Zeng R. et al.: "Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry". Proteomics, 2006, 6, 3352.
29. Miyoshi Y., Nakayama S., Torikoshi Y., Tanaka S., Ishihara H., Taguchi T. et al.: "High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer". Cancer Sci., 2006, 97, 523.
30. Otsuki T., Yata K., Takata-Tomokuni A., Hyodoh F., Miura Y., Sakaguchi H. et al.: "Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells". Br. J. Haematol, 2004, 127, 292.
31. Takano T., Miyauchi A., Matsuzuka F., Yoshida H., Nakata Y., Kuma K. et al.: "PGP9.5 mRNA could contribute to me molecular-based diagnosis of medullary thyroid carcinoma". Eur. J. Cancer, 2004, 40, 614.
32. Yamazaki T., Hibi K., Takase T., Tezel E., Nakayama H., Kasai Y. et al.: "PGP9.5 as a marker for invasive colorectal cancer". Clin. Cancer Res., 2002, 8, 192.
33. Salih H.R., Nussler V.: "Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?". Eur. J. Med. Res., 2001, 6, 323.
34. Sheu B.C., Chiou S.H., Chang W.C., Chow S.N., Lin H.H., Chen R.J. et al.: "Integration of high-risk human papillomavirus DNA correlates with HLA genotype aberration and reduced HLA class I molecule expression in human cervical carcinoma". Clin. Immunol., 2005, 115, 295.
35. Kubier K., Arndt P.F., Wardelmann E., Krebs D., Kuhn W., van der Ven K.: "HLA-class II haplotype associations with ovarian cancer". Int. J. Cancer, 2006, 119, 2980.